Concord Biotech’s IPO opens today, know all the important things before investing in Big Bull’s investment company
[ad_1]
Concord Biotech IPO: IPO of biopharma company Concord Biotech Limited opened in the market today for public subscription. Concord Biotech The company is trying to raise Rs 1551 crore through this IPO. The big thing is that Rakesh Jhunjhunwala, who is called Big Bull of the market, has 24.09 percent stake in this company. He bought this stake through his asset management company Rare Enterprises. However, after his death, now the entire stake has been transferred to his wife Rekha Jhunjhunwala. Let us tell you that retail investors will be able to bid for this IPO from 8 August. The shares of the company were listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) will be listed on.
What is the minimum and maximum amount that can be invested?
The IPO of Concord Biotech Limited has been released today. In this, retail investors can apply for minimum one lot means at least 20 shares. The company has kept the price band of its IPO at Rs 705-741 per share. If an investor wants to invest at least, then according to the upper price band of Rs 741, he will have to invest at least Rs 14,820 for 1 lot. Retail investors can bid for a maximum of 13 lots, ie 260, for which Rs 1,92,660 will have to be invested. Qualified Institutional Investors (QibFor this, about 50 percent stake has been reserved by the company. Apart from this, 35 percent stake has been reserved for retail investors and 15 percent for non-retail investors.
The company sells its products in 70 countries
Concorde Biotech India Based R&D Driven Biopharma Company. Many important medicines are made by the company. They are used in the treatment of diseases like immunity and cancer. Their products are supplied by the company in about 70 countries including India, Japan, America. The company was started in 1984 as ‘Servomed Pharmaceuticals Pvt. Ltd. Happened in the name of Then in the year 2001, the name was changed to ‘Concord Biotech Ltd.’ Done. fermentation based APIs have more than 20% market share in 2022 by volume. According to the information provided by the company, as of June 30, 2023, Concorde Biotech India has 57 brands and 77 products (23 APIs, 53 formulations). At the same time, till March 31, the company also has 3 plants and 2 R&D units in Gujarat.
what is ipo
Full name of IPO Initial Public Offering Is. It is a financial process in which a private company has decided to issue an offer of its stock to investors in the open market. This is the first time for that company that it goes to sell its shares in the open market. When a company issues an IPO, it publicizes its shares and gives investors an opportunity to buy their shares. Through IPO, the company makes its stock available to investors through public and news media so that they can buy it. Through IPO, the company mostly tries to attract new investors for its stock and through this the company collects most of the capital to fulfill its development and financial plans. It is an attractive option for investors as it provides them the opportunity to own a public company.
how to invest in ipo
Before investing in an IPO, go through the relevant documents thoroughly. Investing in it is risky. In this case, take the help of a financial advisor. To subscribe to the IPO, you need to have a demat account. If you do not have one, you can approach a registered stockbroker or Depository Participant (DP) to open a Demat account. Next, choose a registered stockbroker who provides IPO services. You can do this through online trading platforms or by personally visiting the broker’s office. Stay updated with IPO announcements and their details. Information about upcoming IPOs is usually available on the websites of stock exchanges, financial newspapers and the official website of the company issuing the IPO. Once you have selected an IPO that you wish to subscribe to, you can apply either online or offline.
[ad_2]
Source link
